Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Starting cervical cancer screening at 25 years of age: the time has come.

Literature DB >> 30617226

Starting cervical cancer screening at 25 years of age: the time has come.

Cathy Popadiuk¹, Kathleen Decker², Cindy Gauvreau².

Abstract

Entities: Disease

Mesh：

Substances：
Papillomavirus Vaccines

Year: 2019 PMID： 30617226 PMCID： PMC6312515 DOI： 10.1503/cmaj.181312

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

10 in total

1. Prevalence of HPV After Introduction of the Vaccination Program in the United States.

Authors: Lauri E Markowitz; Gui Liu; Susan Hariri; Martin Steinau; Eileen F Dunne; Elizabeth R Unger
Journal: Pediatrics Date: 2016-02-22 Impact factor: 7.124

2. Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis.

Authors: Gina S Ogilvie; Monika Naus; Deborah M Money; Simon R Dobson; Dianne Miller; Mel Krajden; Dirk J van Niekerk; Andrew J Coldman
Journal: Int J Cancer Date: 2015-06-03 Impact factor: 7.396

3. Effect of HPV on cervical cancer screening in Alberta.

Authors: Marc Brisson; Mélanie Drolet; Élodie Bénard; Aimée R Kreimer
Journal: CMAJ Date: 2016-10-04 Impact factor: 8.262

4. Recommendations on screening for cervical cancer.

Authors: James Dickinson; Eva Tsakonas; Sarah Conner Gorber; Gabriela Lewin; Elizabeth Shaw; Harminder Singh; Michel Joffres; Richard Birtwhistle; Marcello Tonelli; Verna Mai; Meg McLachlin
Journal: CMAJ Date: 2013-01-07 Impact factor: 8.262

5. Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.

Authors: C Popadiuk; C L Gauvreau; M Bhavsar; C Nadeau; K Asakawa; W M Flanagan; M C Wolfson; A J Coldman; S Memon; N Fitzgerald; J Lacombe; A B Miller
Journal: Curr Oncol Date: 2016-02-29 Impact factor: 3.677

6. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.

Authors: Jong Kim; Christopher Bell; Maggie Sun; Gordon Kliewer; Linan Xu; Maria McInerney; Lawrence W Svenson; Huiming Yang
Journal: CMAJ Date: 2016-07-04 Impact factor: 8.262

Review 7. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.

Authors: Mélanie Drolet; Élodie Bénard; Marie-Claude Boily; Hammad Ali; Louise Baandrup; Heidi Bauer; Simon Beddows; Jacques Brisson; Julia M L Brotherton; Teresa Cummings; Basil Donovan; Christopher K Fairley; Elaine W Flagg; Anne M Johnson; Jessica A Kahn; Kimberley Kavanagh; Susanne K Kjaer; Erich V Kliewer; Philippe Lemieux-Mellouki; Lauri Markowitz; Aminata Mboup; David Mesher; Linda Niccolai; Jeannie Oliphant; Kevin G Pollock; Kate Soldan; Pam Sonnenberg; Sepehr N Tabrizi; Clare Tanton; Marc Brisson
Journal: Lancet Infect Dis Date: 2015-03-03 Impact factor: 25.071

Review 8. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience.

Authors: Suzanne M Garland; Susanne K Kjaer; Nubia Muñoz; Stan L Block; Darron R Brown; Mark J DiNubile; Brianna R Lindsay; Barbara J Kuter; Gonzalo Perez; Geraldine Dominiak-Felden; Alfred J Saah; Rosybel Drury; Rituparna Das; Christine Velicer
Journal: Clin Infect Dis Date: 2016-05-26 Impact factor: 9.079

9. Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years.

Authors: R Landy; H Birke; A Castanon; P Sasieni
Journal: Br J Cancer Date: 2014-02-11 Impact factor: 7.640

10. Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?

Authors: Alejandra Castanon; Peter Sasieni
Journal: Prev Med Date: 2017-12-13 Impact factor: 4.018